Related Experiment Video
Updated: Jul 5, 2026
06:26
Novel and Innovative Hybrid Technique for Type A Aortic Dissection
Published on: March 28, 2025
Multicenter experience with a new "hybrid" carotid stent
Alberto Cremonesi1, Paolo Rubino, Chiara Grattoni
1Interventional Cardiovascular Unit, Villa Maria Cecilia Hospital, Cotignola, Italy. acremonesi@gvm-vmc.it
Summary
The Cristallo Ideale carotid stent demonstrated excellent safety and effectiveness in a multicenter trial. This new hybrid stent is suitable for carotid artery stenting procedures.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Medical Device Technology
Background:
- Carotid artery stenosis poses a significant risk of stroke.
- Cerebrovascular interventions aim to reduce stroke risk.
- New stent designs are continuously evaluated for improved patient outcomes.
Purpose of the Study:
- To evaluate the safety and performance of the novel Cristallo Ideale hybrid stent.
- To assess the periprocedural outcomes of carotid artery stenting with this new device.
Main Methods:
- Prospective, multicenter registry of 124 patients undergoing carotid stenting.
- Inclusion criteria: >60% symptomatic or >80% asymptomatic carotid stenosis.
- Primary endpoint: 30-day major adverse neurological events; independent adjudication of all events.
Main Results:
- Successful stent deployment in all cases with no technical failures.
- Zero major adverse neurological events at 30 days.
- Two (1.6%) transient ischemic attacks (resolved within 24 hours) and four (3.2%) non-neurological adverse events were reported.
Conclusions:
- The Cristallo Ideale carotid stent is safe and effective in the periprocedural period.
- The hybrid structure facilitates plaque scaffolding and vessel adaptability.
- This device shows promise for carotid artery interventions.
